Ryan Flinn
Contributor
Ryan Flinn has 25 years of experience in media and communications, with roles both as a journalist covering biotech at Bloomberg News and as a Communications Leader at Johnson & Johnson. His articles have been published in The New York Times, the San Francsico Chronicle, Businessweek, Evidence-Based Oncology, Managed Healthcare Executive, and Cure. He is the AI correspondent for BiotechTV and publishes a weekly newsletter, AI Rx, on how AI is transforming health care. He lives in Oakland, California, and has been a professional wine reviewer and competitive sabre fencer in his (limited) free time.
